After attending this knowledge-based educational activity, participants should be able to
- Describe the effect of malignancy on the risk of VTE.
- List risk factors for the development of VTE in cancer patients.
- Summarize evidence-based guidelines for the prevention and treatment of VTE in cancer patients.
- List contraindications to pharmacologic prophylaxis and management of VTE.
- When presented with a patient case, specify the appropriate dose and duration of antithrombotic therapy in the prevention and treatment of VTE in cancer patients and address potential unique patient needs.